Royalty Pharma plc (RPRX)

Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,706	11,334	12,497	17,432	17,116	19,426
Market Cap Growth	-9.30%	-9.30%	-28.31%	1.85%	-11.89%	-
Enterprise Value	25,273	21,332	21,132	27,333	26,687	28,409
Last Close Price	32.29	25.34	27.06	37.12	36.75	45.42
PE Ratio	16.97	13.20	11.01	407.00	27.62	39.23
Forward PE	7.23	6.10	7.47	10.32	13.00	19.16
PS Ratio	6.39	5.01	5.31	7.79	7.48	9.15
PB Ratio	2.07	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	2.69	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	6.73	4.09	4.18	8.13	8.48	9.55
PEG Ratio	0.89	2.14	2.65	0.94	1.12	1.97
EV/Sales Ratio	11.17	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	19.55	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.74	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	1.43	1.43	7.78	2.11	16.77	8.73
Current Ratio	1.44	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	13.03%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	4.67%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital (ROIC)	4.73%	4.73%	5.68%	3.39%	5.41%	7.38%
Return on Capital Employed (ROCE)	7.60%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	460.62%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	271.20%	3.31%	2.96%	2.05%	1.85%	0.66%
Payout Ratio	4602.75%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	145.80%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	418.70%	4.77%	-34.70%	-3.54%	-8.63%	0.66%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q